These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23946555)

  • 21. Probing the simulant behavior of PNPDPP toward parathion and paraoxon: a computational study.
    Khan AS; Bandyopadhyay T; Ganguly B
    J Mol Graph Model; 2012 Apr; 34():10-7. PubMed ID: 22306410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrophotometric determination of paraoxonase within mouse carrier red blood cells.
    Pei L; McGuinn WD; Omburo G; Zitzer AH; Petrikovics I; Way JL
    Biotechnol Appl Biochem; 1994 Aug; 20(1):35-41. PubMed ID: 7917064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
    Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
    Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented hydrolysis of diisopropyl fluorophosphate in engineered mutants of phosphotriesterase.
    Watkins LM; Mahoney HJ; McCulloch JK; Raushel FM
    J Biol Chem; 1997 Oct; 272(41):25596-601. PubMed ID: 9325279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of conformational variability of phosphotriesterase upon N-acyl-L-homoserine lactone and paraoxon binding: insights from molecular dynamics studies.
    Zhan D; Zhou Z; Guan S; Han W
    Molecules; 2013 Dec; 18(12):15501-18. PubMed ID: 24352010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.
    Masurier N; Estour F; Froment MT; Lefèvre B; Debouzy JC; Brasme B; Masson P; Lafont O
    Eur J Med Chem; 2005 Jul; 40(7):615-23. PubMed ID: 15935896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highest paraoxonase turnover rate found in a bacterial phosphotriesterase variant.
    Briseño-Roa L; Oliynyk Z; Timperley CM; Griffiths AD; Fersht AR
    Protein Eng Des Sel; 2011 Jan; 24(1-2):209-11. PubMed ID: 20650962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of active-site amino-acid residues of human serum paraoxonase using competitive substrates.
    Yeung DT; Lenz DE; Cerasoli DM
    FEBS J; 2005 May; 272(9):2225-30. PubMed ID: 15853807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mobility of the active site bound paraoxon and sarin in zinc-phosphotriesterase by molecular dynamics simulation and quantum chemical calculation.
    Koca J; Zhan CG; Rittenhouse RC; Ornstein RL
    J Am Chem Soc; 2001 Feb; 123(5):817-26. PubMed ID: 11456615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substrate-dependent inactivation of recombinant paraoxonase 1 during catalytic dihydrocoumarin turnover and the protective properties of surfactants.
    Smerkolj J; Stojan J; Bavec A; Goličnik M
    Chem Biol Interact; 2023 Sep; 382():110563. PubMed ID: 37286155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum paraoxonase status: a major factor in determining resistance to organophosphates.
    Li WF; Costa LG; Furlong CE
    J Toxicol Environ Health; 1993; 40(2-3):337-46. PubMed ID: 7693961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organophosphate-induced alterations in muscarinic receptor binding and phosphoinositide hydrolysis in the human SK-N-SH cell line.
    Katz LS; Marquis JK
    Neurotoxicology; 1992; 13(2):365-78. PubMed ID: 1331918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism for the hydrolysis of organophosphates by the bacterial phosphotriesterase.
    Aubert SD; Li Y; Raushel FM
    Biochemistry; 2004 May; 43(19):5707-15. PubMed ID: 15134445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell surface display of organophosphorus hydrolase for sensitive spectrophotometric detection of p-nitrophenol substituted organophosphates.
    Tang X; Liang B; Yi T; Manco G; Palchetti I; Liu A
    Enzyme Microb Technol; 2014 Feb; 55():107-12. PubMed ID: 24411452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereochemical constraints on the substrate specificity of phosphotriesterase.
    Hong SB; Raushel FM
    Biochemistry; 1999 Jan; 38(4):1159-65. PubMed ID: 9930975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chimeric proteins combining phosphatase and cellulose-binding activities: proof-of-concept and application in the hydrolysis of paraoxon.
    Gonçalves LM; Chaimovich H; Cuccovia IM; Marana SR
    Protein Pept Lett; 2014 May; 21(5):468-75. PubMed ID: 24555432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural characterization and reversal of the natural organophosphate resistance of a D-type esterase, Saccharomyces cerevisiae S-formylglutathione hydrolase.
    Legler PM; Kumaran D; Swaminathan S; Studier FW; Millard CB
    Biochemistry; 2008 Sep; 47(36):9592-601. PubMed ID: 18707125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities.
    Gan KN; Smolen A; Eckerson HW; La Du BN
    Drug Metab Dispos; 1991; 19(1):100-6. PubMed ID: 1673382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The molecular basis of the human serum paraoxonase activity polymorphism.
    Humbert R; Adler DA; Disteche CM; Hassett C; Omiecinski CJ; Furlong CE
    Nat Genet; 1993 Jan; 3(1):73-6. PubMed ID: 8098250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico analyses of substrate interactions with human serum paraoxonase 1.
    Hu X; Jiang X; Lenz DE; Cerasoli DM; Wallqvist A
    Proteins; 2009 May; 75(2):486-98. PubMed ID: 18951406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.